| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
30,113 |
25,058 |
$4.61M |
| 90834 |
Psychotherapy, 45 minutes with patient |
37,400 |
26,324 |
$4.54M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
22,051 |
19,327 |
$3.36M |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
45,976 |
14,696 |
$2.51M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
713 |
584 |
$1.24M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
19,916 |
12,068 |
$1.07M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,849 |
6,785 |
$979K |
| 90832 |
Psychotherapy, 30 minutes with patient |
5,525 |
4,553 |
$662K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
8,096 |
7,011 |
$660K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,680 |
5,152 |
$549K |
| 90791 |
Psychiatric diagnostic evaluation |
4,772 |
4,302 |
$546K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
906 |
388 |
$518K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
110 |
108 |
$470K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
6,004 |
4,653 |
$387K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
929 |
772 |
$381K |
| 71045 |
Radiologic examination, chest; single view |
2,123 |
1,794 |
$336K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,183 |
4,081 |
$335K |
| Q3014 |
Telehealth originating site facility fee |
6,738 |
3,612 |
$267K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,374 |
1,141 |
$178K |
| 93017 |
|
1,179 |
952 |
$173K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
394 |
331 |
$152K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,442 |
3,562 |
$147K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,248 |
4,012 |
$138K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
32,368 |
24,092 |
$131K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
517 |
258 |
$96K |
| 90837 |
Psychotherapy, 53 minutes with patient |
563 |
436 |
$82K |
| 59025 |
Fetal non-stress test |
263 |
186 |
$81K |
| 36415 |
Collection of venous blood by venipuncture |
31,479 |
23,686 |
$78K |
| 71046 |
Radiologic examination, chest; 2 views |
615 |
563 |
$63K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
132 |
101 |
$56K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
756 |
675 |
$55K |
| 93458 |
|
14 |
12 |
$53K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
11,051 |
8,397 |
$52K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
282 |
260 |
$45K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
394 |
357 |
$45K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
607 |
525 |
$42K |
| 80053 |
Comprehensive metabolic panel |
8,236 |
5,510 |
$38K |
| 99215 |
Prolong outpt/office vis |
239 |
193 |
$31K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
468 |
409 |
$30K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
874 |
587 |
$29K |
| 71250 |
|
209 |
161 |
$27K |
| 99221 |
|
75 |
57 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,582 |
2,117 |
$23K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
63 |
47 |
$19K |
| J2785 |
Injection, regadenoson, 0.1 mg |
148 |
132 |
$17K |
| 80061 |
Lipid panel |
1,817 |
1,535 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
273 |
252 |
$10K |
| 84484 |
|
1,352 |
954 |
$10K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
444 |
389 |
$9K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
13 |
12 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,593 |
1,368 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
563 |
411 |
$8K |
| 99218 |
|
38 |
27 |
$8K |
| 99217 |
|
37 |
26 |
$8K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
156 |
141 |
$8K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
187 |
116 |
$7K |
| 84480 |
|
1,051 |
903 |
$6K |
| 80050 |
General health panel |
32 |
25 |
$5K |
| 80305 |
|
594 |
317 |
$5K |
| 77336 |
|
25 |
14 |
$5K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
161 |
126 |
$5K |
| 80076 |
|
743 |
617 |
$4K |
| A0425 |
Ground mileage, per statute mile |
479 |
279 |
$4K |
| 84439 |
|
646 |
500 |
$4K |
| 84436 |
|
1,134 |
980 |
$4K |
| 83690 |
|
951 |
768 |
$4K |
| 81001 |
|
2,005 |
1,608 |
$4K |
| 94060 |
|
157 |
142 |
$4K |
| 85027 |
|
1,134 |
982 |
$3K |
| G0378 |
Hospital observation service, per hour |
38 |
13 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
30 |
25 |
$3K |
| 80081 |
|
44 |
41 |
$3K |
| 82728 |
|
313 |
265 |
$3K |
| 81025 |
|
454 |
380 |
$3K |
| 77300 |
|
22 |
12 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
416 |
338 |
$2K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
35 |
30 |
$2K |
| 83550 |
|
289 |
246 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
839 |
341 |
$2K |
| 94726 |
|
123 |
118 |
$2K |
| 87634 |
|
30 |
25 |
$1K |
| 83540 |
|
293 |
248 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
123 |
56 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
41 |
40 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
29 |
27 |
$952.74 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
29 |
27 |
$952.74 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
88 |
79 |
$914.88 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
41 |
26 |
$903.57 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
27 |
26 |
$885.71 |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
34 |
26 |
$759.88 |
| 82950 |
|
173 |
153 |
$671.49 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
29 |
28 |
$638.39 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13 |
13 |
$513.02 |
| 96376 |
|
79 |
29 |
$442.26 |
| 80069 |
|
197 |
119 |
$418.58 |
| 80055 |
|
13 |
12 |
$405.35 |
| 82947 |
|
64 |
14 |
$324.56 |
| 87088 |
|
77 |
58 |
$320.29 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
30 |
28 |
$319.05 |
| 83880 |
|
15 |
14 |
$314.08 |
| 82607 |
|
27 |
24 |
$214.90 |
| 82746 |
|
27 |
24 |
$209.54 |
| 86364 |
|
16 |
15 |
$164.16 |
| 82784 |
|
16 |
15 |
$132.95 |
| T2003 |
Non-emergency transportation; encounter/trip |
16 |
13 |
$126.50 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
401 |
357 |
$112.81 |
| 82043 |
|
28 |
27 |
$111.77 |
| 82570 |
|
30 |
29 |
$102.77 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
19 |
12 |
$102.06 |
| 83735 |
|
25 |
12 |
$87.10 |
| 82553 |
|
42 |
25 |
$48.78 |
| 85014 |
|
31 |
24 |
$47.18 |
| 85018 |
|
31 |
24 |
$46.08 |
| C1769 |
Guide wire |
31 |
24 |
$31.20 |
| J1644 |
Injection, heparin sodium, per 1000 units |
291 |
126 |
$28.68 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
284 |
177 |
$26.34 |
| 94729 |
|
134 |
129 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
207 |
178 |
$0.00 |
| 99188 |
|
30 |
25 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
44 |
14 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
13 |
12 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
12 |
12 |
$0.00 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
19 |
19 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
257 |
201 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
133 |
121 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
320 |
276 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
114 |
103 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
39 |
29 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
110 |
99 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
24 |
24 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
39 |
24 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
29 |
24 |
$0.00 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
33 |
29 |
$0.00 |